Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
OMCL — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

8.17

Margin Of Safety %

54

Put/Call OI Ratio

0.28

EPS Next Q Diff

-0.33

EPS Last/This Y

2.23

EPS This/Next Y

-0.18

Price

36.82

Target Price

57.86

Analyst Recom

1.25

Performance Q

-15.05

Upside

-70.0%

Beta

0.98

Ticker: OMCL




19 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-07-13OMCL46.681.470.962554
2026-07-14OMCL45.981.328.912687
2026-07-15OMCL46.841.340.502718
2026-07-16OMCL46.991.340.062722
2026-07-17OMCL45.841.330.602728
2026-07-20OMCL45.240.211.501362
2026-07-21OMCL41.80.220.891376
2026-07-22OMCL40.840.236.001402
2026-07-23OMCL39.830.312.001496
2026-07-24OMCL41.010.330.001514
2026-07-27OMCL41.490.330.001516
2026-07-28OMCL43.030.330.831517
2026-07-29OMCL41.330.330.451534
2026-07-30OMCL37.10.331.681539
2026-07-31OMCL35.40.340.031561
2026-08-03OMCL37.60.340.701569
2026-08-04OMCL37.120.312.001604
2026-08-05OMCL37.150.310.001609
2026-08-07OMCL36.780.280.101660
DateSymbolLatestP/C OIP/C VolTotal OI
19 items Current Page1 of 1




20 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-07-13OMCL46.663.9- 1.94
2026-07-14OMCL45.943.9- 1.94
2026-07-15OMCL46.803.9- 1.94
2026-07-16OMCL47.003.9- 1.94
2026-07-17OMCL45.853.9- 1.94
2026-07-20OMCL45.183.9- 1.94
2026-07-21OMCL41.843.9- 1.94
2026-07-22OMCL40.833.9- 1.94
2026-07-23OMCL39.823.9- 1.94
2026-07-24OMCL40.973.9- 1.94
2026-07-27OMCL41.503.9- 1.94
2026-07-28OMCL43.043.9- 1.94
2026-07-29OMCL41.373.9- 1.94
2026-07-30OMCL37.143.9- 1.94
2026-07-31OMCL35.373.9- 1.94
2026-08-03OMCL37.623.9- 1.94
2026-08-04OMCL37.623.9- 1.94
2026-08-05OMCL37.17-16.2- 2.14
2026-08-06OMCL36.20-16.2- 2.14
2026-08-07OMCL36.82-18.1- 2.27
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
20 items Current Page1 of 1




20 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-07-13OMCL-1.240.127.24
2026-07-14OMCL-1.240.127.24
2026-07-15OMCL-1.230.127.24
2026-07-16OMCL-1.230.127.24
2026-07-17OMCL-1.230.127.24
2026-07-20OMCL-1.85-0.867.24
2026-07-21OMCL-1.85-0.867.24
2026-07-22OMCL-1.85-0.867.24
2026-07-23OMCL-1.85-0.867.24
2026-07-24OMCL-1.86-0.867.24
2026-07-27OMCL-1.86-0.668.17
2026-07-28OMCL-1.86-0.668.17
2026-07-29OMCL-1.86-0.668.17
2026-07-30OMCL-1.86-0.668.17
2026-07-31OMCL-1.86-0.668.17
2026-08-03OMCL-1.86-0.328.17
2026-08-04OMCL-1.86-0.328.17
2026-08-05OMCL-1.86-0.328.17
2026-08-06OMCL-1.86-0.328.17
2026-08-07OMCL-1.86-0.328.17
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
20 items Current Page1 of 1

Last Quarter Act. EPS

0.7

Avg. EPS Est. Current Quarter

0.42

Avg. EPS Est. Next Quarter

0.37

Insider Transactions

-1.86

Institutional Transactions

-0.32

Beta

0.98

Average Sales Estimate Current Quarter

304

Average Sales Estimate Next Quarter

310

Fair Value

56.82

Quality Score

49

Growth Score

69

Sentiment Score

33

Actual DrawDown %

80.3

Max Drawdown 5-Year %

-86.6

Target Price

57.86

P/E

43.53

Forward P/E

17.61

PEG

1.18

P/S

1.35

P/B

1.3

P/Free Cash Flow

11.98

EPS

0.85

Average EPS Est. Cur. Y​

2.27

EPS Next Y. (Est.)

2.09

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

3.13

Relative Volume

1.07

Return on Equity vs Sector %

-24.3

Return on Equity vs Industry %

-7.7

EPS 1 7Days Diff

0.3

EPS 1 30Days Diff

0.33

EBIT Estimation

OMCL Healthcare
$36.81
📉
Swing / Pullback
Buy the dip on strong trends
N/A
0 /100
WEAK
Trend
6/20
Pullback
19/25
Volume
1/15
Valuation
20/20
TP/AR
2/10
Options
7/10
RSI
38.7
Range 1M
17.9%
Sup Dist
3.1%
🚀
Momentum Growth
Ride accelerating trends
N/A
37 /100
WEAK
Momentum
2/25
Growth
20/30
Estimates
3/20
Inst/Vol
2/15
Options
10/10
EPS Yr
40.1%
EPS NY
-7.9%
52W%
31.5%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
🟡 HOLD +14.7% upside
Quality
6/30
Valuation
15/30
Growth
14/25
Stability
7/10
LT Trend
2/5
Upside
+14.7%
Quality
49
MoS
54%
OMCL — P/E HistoricalHealth Information Services
Omnicell, Inc.
Sector: Healthcare
Industry: Health Information Services
Employees: 3485
Omnicell, Inc., together with its subsidiaries, provides healthcare technology in the United States and internationally. It offers hospital and health systems solutions, such as points of care for clinician workflows in patient care areas of the healthcare system; Titan XT, an automated dispensing system; XTExtend, a console swap for its XT cabinets; and Central Pharmacy Dispensing Service for the medication dispensing process. The company also provides Central Med Automation Service for medication dispensing; IV Compounding Service, an in-house compounding system; specialty pharmacy services, including turnkey solution to help health systems establish, manage, and optimize an entity-owned specialty pharmacy; EnlivenHealth platform to digitally enable retail and community pharmacies; medication adherence solutions comprising consumables and medication packaging systems; and technology implementation, customer education and training, program management, and related offerings to professional services. In addition, it offers post-installation support and maintenance via phone and/or web, on-site service, parts, and access to software upgrades; software and hardware products for full traceability of medicines and medical supplies throughout the healthcare system; OmniSphere, a cloud-based platform. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.
OMCL

Latest News

Caricamento notizie per OMCL
stock quote shares OMCL – Omnicell, Inc. Stock Price stock today
news today OMCL – Omnicell, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch OMCL – Omnicell, Inc. yahoo finance google finance
stock history OMCL – Omnicell, Inc. invest stock market
stock prices OMCL premarket after hours
ticker OMCL fair value insiders trading